Press releases

Osmind and UBC partner to Advance Mental Health Treatment Through REMS Innovation

October 29, 2024

Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

May 2, 2024

Osmind Reimagines Insurance Reimbursement for Psychiatric Clinicians, Expanding Patient Access to Mental Health Care

October 24, 2023

Osmind launches integrated virtual visits, expanding care options for in-demand mental health clinicians

September 15, 2022

Osmind Raises $40M Series B Round Led by DFJ Growth to Expand Platform for Breakthrough Mental Health Research and Treatment

May 10, 2022

Osmind Announces Appointment of Brent Saunders, Pharma Veteran and Former CEO of Allergan, to Board of Directors ‍

January 21, 2022

Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression ‍

January 11, 2022

Osmind Expands Senior Leadership Team With Addition of Chief Growth Officer and Scientific Advisory Board Members ‍

January 4, 2022

Osmind Closes $15 Million Series A Round to Help Clinicians and Researchers Bring Innovative Mental Health Treatments to More Patients ‍‍

July 1, 2021

New Study Asks Clinicians to Help Shape the Future Of Psychedelic Integration Therapy ‍

June 21, 2021

Dr. Robin Carhart-Harris Joins Osmind as a Scientific Advisor

February 4, 2021

Ketamine Taskforce for Access to Safe Care and Insurance Coverage Launches, Offering Hope to Chronic Pain and Mental Health Patients ‍

February 1, 2021

Osmind Raises $2M Seed Round to Revolutionize Mental Health by Empowering Mental Health Patients, Clinicians, and Researchers ‍

October 14, 2020

View older posts

logo

Insights

AboutCareersBlogPodcastAffiliate

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.

Osmind Inc. © 2024 All Rights Reserved.

Privacy Policy

Terms of Service